German drug manufacturer Bayer has recently hit a new 52-week high and may be subject to some profit-taking; overbought stochastics have crossed and may signal lower prices. The recent 2-month uptrend has today been breached. Current prices may provide entry to a possible short position targeting Fibonacci retracement levels. Stop-loss close above $50.
No comments:
Post a Comment